scholarly journals Cancer Mortality Trends in Spain (2000–2016): Differences between Immigrant and Native Populations

Author(s):  
Adriana Oliva-Arocas ◽  
Pamela Pereyra-Zamora ◽  
José M. Copete ◽  
Andreu Nolasco

Spain’s population has changed thanks to recent immigration. Therefore, a new epidemiological and demographic profile has been generated in the country. This study aims to analyze immigrant and native cancer mortality trends in Spain for the period 2000 to 2016. An ecological study of trends was carried out. Age-standardized rates of cancer mortality (ASR) and annual percentage change (APC) between groups and study sub-periods were calculated. Significant decreases in ASR were observed for cancer in both the native and the immigrant populations, in both men and women. However, in 2014–2016, there was an increase in ASR in the immigrant population compared to 2011–2013, due to the increase in ASR among immigrants from European regions. Differences in ASR by cancer between immigrant and native populations residing in Spain have been identified, both in the rate of decline and magnitude as well as by the birth region of the immigrant population. The increase observed in the cancer mortality trend at the end of the period in some immigrant groups indicates the need to monitor these indicators given the demographic, social, and economic changes.

2021 ◽  
Author(s):  
Diego Rodrigues Mendonça e Silva ◽  
Max Moura Oliveira ◽  
Gisele Aparecida Fernandes ◽  
Maria Paula Curado

Abstract Pancreatic cancer mortality is greatest in countries with a high and very high Human Development Index (HDI). The aim was to evaluate the pancreatic cancer mortality rates and trends related to HDI in Brazil by state. An ecological study was conducted on pancreatic cancer mortality in Brazilian states between 1979 and 2019. Age-standardized mortality rates (ASMR) and Annual Average Percent Change (AAPC) were calculated. Pearson´s correlation test was applied to compare rates over the 3 decades from 1986-2015 to verify correlation between change in HDI from 1991 to 2010. A total of 209,425 deaths from pancreatic cancer were reported in Brazil from 1979 to 2019. In men, ASMRs ranged from 2.9/100,000 in 1979 to 6.1/100,000 in 2019, with AAPC of 1.5% per year, and in women, ASMR ranged from 2.1/100,000 in 1979 to 4.7/100,000 in 2019, with AAPC of 1.9% per year. Mortality rates and trends increase with higher % of HDI improvement with a correlation between ASMRs and HDI above r>0.80. The mortality trends in pancreatic cancer were uneven increase in Brazil, there was an upward trend in mortality in both genders, but higher among women. Pancreatic cancer mortality trends were higher in those states where there was greatest increase in HDI, regions as North and Northeast. However, mortality rates remain higher in South, Southeast and Central-West of Brazil.


2021 ◽  
Vol 39 (15_suppl) ◽  
pp. 572-572
Author(s):  
Yunan Han ◽  
Shuai Xu ◽  
Graham A. Colditz ◽  
Adetunji T. Toriola

572 Background: Breast cancer is the second leading cause of cancer death in U.S. women. On the molecular level, breast cancer is a heterogeneous disease. Heterogeneous expressions of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) are etiologically and clinically meaningful, as they map to distinct risk factors and different treatment strategies. Although breast cancer mortality has been declining since 1990, little is known about mortality trends according to molecular subtypes at the population level. Methods: We examined the incidence-based mortality rates and trends among women who were diagnosed with invasive breast cancer from 2010 through 2017 using the Surveillance, Epidemiology, and End Results (SEER) database. We defined incidence-based mortality using a moving 5-year calendar period starting in 2014. We further assessed mortality according to breast cancer molecular subtypes: luminal A (ER and/or PR positive, HER2 negative), luminal B (ER and/or PR positive, HER2 positive), HER2-enriched (HER2 over-expressed or amplified, ER and PR negative) and triple-negative (ER and PR negative, HER2 negative) tumors. We calculated annual percent changes (APC) in incidence-based mortality using joinpoint regression models. Results: Overall, incidence-based mortality for breast cancer significantly decreased by 1.5% annually from 2014 through 2017 (APC, -1.5%; 95% coefficient interval [CI], -2.3% to -0.7%; p<0.001). Incidence-based mortality decreased annually by 2.0% for luminal A breast cancer (APC, -2.0%; 95% CI, -3.7% to -0.3%; p<0.001), 2.1% for luminal B breast cancer (APC, -2.1%; 95% CI, -5.4% to 1.4%; p=0.1), 1.1% for triple-negative breast cancer (TNBC) (APC, -1.1%; 95% CI, -2.1% to -0.0%; p<0.001). However, incidence-based mortality for HER2-enriched breast cancer increased 2.3% annually during the study period (APC, 2.3%; 95% CI, -2.4% to 7.2%; p=0.2). Conclusions: Between 2014 and 2017, incidence-based mortality for luminal A, luminal B, and TNBC decreased among U.S. women, with a larger decrease observed for luminal tumors. However, incidence-based mortality for HER2-enriched breast cancer increased. The favorable incidence-based mortality trends for luminal tumors and TNBC are likely due to the continuing improvement in treatments and early detection. The increasing trend of incidence-based mortality for HER2-enriched breast cancer constitutes a priority for cancer control activities and further research.


2016 ◽  
Vol 116 (6) ◽  
pp. 370
Author(s):  
Katie N. Kennedy ◽  
Susan L. Meacham ◽  
Suporn Sukpraprut ◽  
Stephanie S. Kwakye ◽  
Kristy K. Atkinson ◽  
...  

BMC Cancer ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Daniel Mak ◽  
Mazvita Sengayi ◽  
Wenlong C. Chen ◽  
Chantal Babb de Villiers ◽  
Elvira Singh ◽  
...  

2002 ◽  
Vol 130 (5-6) ◽  
pp. 173-177 ◽  
Author(s):  
Olga Gajic-Veljanoski ◽  
Mirjana Jarebinski ◽  
Ana Jovicevic-Bekic ◽  
Tatjana Pekmezovic

Colorectal cancer is one of the most frequent malignant neoplasms in both sexes within developed countries. In the Republic of Serbia(Serbia) colorectal cancer mortality in 1971 ranged 5 in females, and 4 in males; it became the second leading malignancy in 1982 in females (after breast cancer), and in 1992 in males (after lung cancer). The objective of this descriptive-epidemiological study was to examine colorectal cancer mortality in Serbian population, particularly the effect of cohort variations on death rates in defined age groups over the period 1971-1996. Mortality rates were calculated from unpublished national vital statistics data of the Institute of Statistics of the Republic of Serbia. To estimate the age effect on colorectal cancer mortality, specific death rates were computed for cohorts born between 1892-96 and 1972-76, and died at subsequent time periods. The mortality rates were adjusted by direct method, using the world standard population. Confidence intervals (CI) for death rates were assessed with 95% level of probability. In time trend analysis of mortality, Fisher's test was used as a significance test for linear regression coefficient. In the study period (1971-1996), a share of all digestive tumors in cancer mortality has decreased from 42.0% to 32.3%. However, the mortality risk of colorectal cancer and its share in cancer mortality have increased. For example, in men, the share of colorectal cancer in digestive cancer mortality increased from 20.7% (1971) to 32.8% (1996) and in overall cancer mortality from 7.5% to 10.5%. In women, the share of colorectal cancer in digestive cancer mortality increased from 23.0%(1971) to 35.6%(1996), and in overall cancer mortality from 8.5% to 11.6%. The average colorectal cancer age-adjusted death rates (1971-1996) were 11.2 per 100,000 men (95% CI: 10.1-12.3), and 8.3 per 100,000 women (95% CI: 7.7-8.9). The secular linear mortality trends showed significant increase both in males (y = 11.2 + 0.2x; ? = 0.000), and females (y = 8.3 + 0.1 ?; ? = 0.000). The highest rise in age-specific death rates, according to linear mortality trends, was observed in males over 65 years (7.8% annually), and females between 60 and 69 years (5.9% annually). In cohort analysis of age-specific rates in males, younger birth cohorts were compared with older ones. The increasing colorectal cancer mortality risk has been observed for ages over 40, with statistical significance in age groups over 45. In ages between 45 and 59, and over 60, the youngest birth cohorts were at 2 and 2.5-fold higher cancer mortality risk than birth cohorts of the oldest generations. For example, the age specific colorectal cancer death rates in a 70-74 year group were 2.5-fold higher in men born between 1922 and 1926 (139.3/100,000) than in cohorts born 25 years earlier (58.7/100,000). In cohort analysis of age-specific rates in females, changes in the age under 50 were not so expressive. In all age groups over 50, women of younger generations were at 2-fold higher cancer mortality risk than the oldest ones. The age specific colorectal cancer death rates in a 65-69 year group were doubled in women born between 1927 and 1931 (61.0/100 000), than in cohorts born 25 years earlier (30.5/100 000). According to the present mortality trends, the further increase in colorectal cancer death rates especially in the ages over 40, should be expected in future generations. Consistent increase in mortality risk in all younger birth cohorts of older ages, as well as in successive five-year age groups of the observed generations, could reflect the continuous increase in colorectal cancer incidence attributed to predominantly environmental exposures.


2020 ◽  
Vol 46 (2) ◽  
Author(s):  
Fábia Cheyenne Gomes de Morais Fernandes ◽  
Samara Carollyne Mafra Soares ◽  
Héllyda De Souza Bezerra ◽  
Dyego Leandro Bezerra De Souza ◽  
Isabelle Ribeiro Barbosa

2014 ◽  
Vol 22 (7) ◽  
pp. 5395-5404 ◽  
Author(s):  
Kai Chen ◽  
Qi Lin Liao ◽  
Zong Wei Ma ◽  
Yang Jin ◽  
Ming Hua ◽  
...  

2018 ◽  
Vol Volume 10 ◽  
pp. 1249-1273 ◽  
Author(s):  
Daniel Medenwald ◽  
Dirk Vordermark ◽  
Christian Dietzel

Sign in / Sign up

Export Citation Format

Share Document